Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphism discovery in 51 chemotherapy pathway genes.

Human molecular genetics - 1 Dec 2005

Freimuth Robert R, Xiao Ming, Marsh Sharon, Minton Matthew, Addleman Nicholas, Van Booven Derek J, McLeod Howard L, Kwok Pui-Yan

Abstract excerpt

Candidate gene pharmacogenetic studies offer a strategy for the rapid assessment of putative predictive markers. As a first step toward studying the pharmacogenetics of cancer chemotherapy, 51 candidate genes from the pathways of antineoplastic agents were resequenced to identify common genetic polymorphisms that might alter therapeutic response or toxicity. Forty DNA samples were screened from each of three...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Ethnicity
Share to Gene Frequency

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Share to Sequence Analysis, DNA

Source

Identifiers

PMID: 16239245
DOI: 10.1093/hmg/ddi387

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphism discovery in 51 chemotherapy pathway genes.PMID 16239245Read ↗

Cancer pharmacogenetics: polymorphisms, pathways and beyond.Semantic proximity Read ↗

Cancer pharmacogenetics.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics of anticancer agents.Semantic proximity Read ↗

Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.Semantic proximity Read ↗

Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.Semantic proximity Read ↗

Studying genetic variations in cancer prognosis (and risk): a primer for clinicians.Semantic proximity Read ↗

Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity.Semantic proximity Read ↗

Genome-wide discovery of loci influencing chemotherapy cytotoxicitySemantic proximity Read ↗

Integration of genetic and functional genomics data to uncover chemotherapeutic induced cytotoxicity.Semantic proximity Read ↗

From Genes to Personalized Cancer Care: A Systematic Review of Toxicity-Associated Genetic Variants in Solid Tumor TreatmentsSemantic proximity Read ↗

Pharmacogenomic Characterization of US FDA-approved Cytotoxic DrugsSemantic proximity Read ↗

Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.